Cargando…
Cripto-1 vaccination elicits protective immunity against metastatic melanoma
Metastatic melanoma is a fatal disease that responds poorly to classical treatments but can be targeted by T cell-based immunotherapy. Cancer vaccines have the potential to generate long-lasting cytotoxic CD8(+) T cell responses able to eradicate established and disseminated tumors. Vaccination agai...
Autores principales: | Ligtenberg, M. A., Witt, K., Galvez-Cancino, F., Sette, A., Lundqvist, A., Lladser, A., Kiessling, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910727/ https://www.ncbi.nlm.nih.gov/pubmed/27467944 http://dx.doi.org/10.1080/2162402X.2015.1128613 |
Ejemplares similares
-
Expression and functional role of CRIPTO-1 in cutaneous melanoma
por: De Luca, A, et al.
Publicado: (2011) -
Vaccination-induced skin-resident memory CD8(+) T cells mediate strong protection against cutaneous melanoma
por: Gálvez-Cancino, Felipe, et al.
Publicado: (2018) -
Cripto-1 in TNBC
por: Castro, Nadia P, et al.
Publicado: (2015) -
Lymphangiogenesis-inducing vaccines elicit potent and long-lasting T cell immunity against melanomas
por: Sasso, Maria Stella, et al.
Publicado: (2021) -
Expression of cripto in Human Pancreatic Tumors
por: Tsutsumi, Masahiro, et al.
Publicado: (1994)